Immediate Impact
3 from Science/Nature 62 standout
Citing Papers
Immune evasion, infectivity, and fusogenicity of SARS-CoV-2 BA.2.86 and FLip variants
2024 Standout
The scope of the antimicrobial resistance challenge
2024 Standout
Works of Ronald Nahass being referenced
Comparative Efficacy of Early COVID-19 Monoclonal Antibody Therapies: A Retrospective Analysis
2022
Risk Factors and Outcomes of Hospitalized Patients With Severe Coronavirus Disease 2019 (COVID-19) and Secondary Bloodstream Infections: A Multicenter Case-Control Study
2020
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Ronald Nahass | 898 | 681 | 425 | 61 | 1.3k | |
| Jeff Powis | 907 | 311 | 481 | 80 | 1.6k | |
| Elina Kolho | 906 | 495 | 274 | 35 | 1.4k | |
| Alison D. Lydecker | 1211 | 687 | 272 | 30 | 1.6k | |
| Javier Murillas | 728 | 588 | 655 | 46 | 1.5k | |
| Jeffrey Topal | 568 | 121 | 447 | 70 | 1.2k | |
| Amr Kandeel | 811 | 285 | 403 | 47 | 1.4k | |
| Edson Abdala | 839 | 195 | 412 | 102 | 1.5k | |
| Mei Chong | 859 | 363 | 219 | 57 | 1.4k | |
| Stefano Ongarello | 494 | 183 | 515 | 44 | 1.3k | |
| Hae Suk Cheong | 415 | 131 | 280 | 51 | 989 |
All Works
Login with ORCID to disown or claim papers
Loading papers...